Indian API Drug Maker Shasun To Expand Japanese Market
This article was originally published in PharmAsia News
Executive Summary
Indian active pharmaceutical ingredient maker Shasun Chemicals and Drugs plans to expand into the Japanese market, announced by Shasun VP Michel Spagnol at a March 3 Tokyo briefing. The company established Japanese subsidiary Shasun Japan last year, and has set sales goal of $7 million for 2009. Shasun looks to expand into the clinical research business and API and drug medium production in Japan. The company also plans to collaborate with Japanese domestic drug makers. (Click here for more - Japanese language